Hypertension
Hypertension Basics
Definition: High blood pressure (BP) characterized by consistent readings >140 mmHg systolic and >90 mmHg diastolic.
Normal BP reading: 120/80 mmHg (systolic/diastolic).
Importance of Measuring BP
BP is vital for organ function and waste removal; an absence can lead to shock or death.
Proper Measurement: Requires avoiding food, caffeine, tobacco, and alcohol 30 mins beforehand; sitting calmly for 5 mins; correct arm positioning and cuff size.
Take repeat reading 1-3 minutes after first reading
Too small cuff size → may measure too high; too large cuff size → may measure too low
Cuff higher than heart → reading may be too low; cuff lower than heart → reading may be too high
Check the patient’s HR as well (e.g. slow HR + high BP = possible concern)
Prevalence
Affects approximately 1.28 billion adults; common in low/middle-income countries.
Types of Hypertension
Primary (Essential) Hypertension:
Most common type (accounts for 90-95% of cases).
Chronic condition not linked to/caused by an underlying condition
Often linked to lifestyle factors (diet, activity, stress) and genetic predisposition.
Secondary Hypertension:
Caused by an underlying, identifiable condition.
Tends to appear suddenly and cause higher BP than primary hypertension.
Causes include:
Kidney disease
Pheochromocytoma: adrenal gland tumors
Thyroid dysfunction
Obstructive sleep apnea
Certain medications (e.g. stimulants, some NE based antidepressants, decongestants (causes vasoconstriction → higher BP), NSAIDS).
Malignant Hypertension:
Hypertensive crisis (SBP >= 180 mmHg or DBP >= 120 mmHg)
Sudden increase in BP in people who already have high BP
May cause stroke, kidney failure, other end organ damage
Due to poor control of hypertension (e.g. non-adherence to medication, unknown HTN)
Requires rapid reduction of BP to ~160 mmHg to prevent tissue damage
Lowering beyond 160 too quickly can cause hypotension symptoms
Stages of Hypertension
Normal: SBP < 120 and DBP < 80
Elevated: SBP 120-129 and DBP < 80
Stage 1 Hypertension: SBP 130-139 or DBP 80-89
Stage 2 Hypertension: SBP >= 140 or DBP >= 90
Hypertensive Crisis: SBP > 180 or DBP > 120
Symptoms of Hypertension
Most patients do not show any symptoms of hypertension
If the patient’s BP is > 180120 they may experience:
Severe headaches
Chest pain (a sign that the patient may experience a cardiovascular event soon)
Dizziness
Difficulty breathing, nausea, vomiting
Blurred vision/other vision changes
Anxiety (may be heading towards MI), confusion (may be heading towards stroke), tinnitus
Nosebleeds (i.e. burst vessels in the nose because of high BP)
arrhythmia
Complications of Hypertension
Inflammation and death of arterioles
Narrowing of blood vessels; arteriosclerosis
Restriction of blood flow to organs (kidney, brain, eye) → tissue damage
Left ventricle enlargement, which can trigger/exacerbate heart failure, angina
Sexual dysfunction
Cognitive impairment
Pulmonary edema
Risk Factors
Modifiable: Unhealthy diet, physical inactivity, tobacco/alcohol use, obesity, stress.
Non-modifiable: Age (>65), genetic predisposition, certain races (higher risk in Black, Hispanic, Asian adults).
Goals of Therapy
Promote lifestyle changes (reduce stress, healthy diet, exercise).
Target BP readings (if they have high BP, we want to get down to these levels): Home <135/85 mmHg, Office <140/90 mmHg.
Isolated systolic hypertension target: < 140 mmHg (150 mmHg if >= 80 years old)
Diabetes mellitus target: < 130/80 mmHg
Non-Pharmacological Treatments
Dietary recommendations: Reduce sodium intake, DASH diet, weight loss, and regular physical activity (150 mins/week).
19-50 years old: 1500 mg/day sodium intake
51-70 years old: 1300 mg/day sodium intake
>= 71 years old: 1200 mg/day sodium intake
Pharmacological Treatments
Common Classes:
ACE Inhibitors (ACEI): Block angiotensin conversion from AT I to AT II; first-line therapy (e.g., Lisinopril, Enalapril).
AT II is a potent vasoconstrictor and promotes aldosterone and norepinephrine release
Drug of choice for secondary hypertension caused by chronic kidney disease, diabetes, CAD, recent MI, and heart failure
not recommended as first-line therapy for African-American patients
Very rarely causes dry cough, hyperkalemia, angioedema
ARBs (-sartan): Block AT II receptors (e.g., Losartan, Valsartan).
First-line therapy if patient cannot tolerate ACE Inhibitors
Beta Blockers: Control heart rate (e.g., Metoprolol); given for younger patients (< 60 years old), stable angina, heart failure (start low and titrate slowly), history of MI, migraines, tachycardia, essential tremor
Block the release of adrenaline and noradrenaline in certain parts of the body
First-generation: Nonselective antagonists of beta-1 (heart) and beta-2 (lungs) receptors
Second-generation: Dose dependent beta-1 receptor antagonists
Third-generation: beta-1 receptor antagonists and vasodilators
Can cause slow HR, cold hands and feet, sleep disturbances, nausea/vomiting, sexual dysfunction, blurred vision, dry mouth/eyes
Contraindicated in patients with acute/chronic bradycardia and/or hypotension. Nonselective beta blockers should not be used in patients with asthma (cardio-selective may be allowed)
Avoid stopping abruptly, as this can cause arrhythmia or angina
Calcium Channel Blockers (CCB): Lower blood pressure by preventing calcium from entering cells of the heart and blood vessels (vasodilator) (e.g., Amlodipine, Verapamil).
Non-dihydropyridines: slow HR and cause vasodilation
Dihydropyridines: mainly cause peripheral vasodilation
Long acting dihydropyridine (DHP) CCBs can be used as first line; short-acting may increase risk of cardiovascular events
Effective in elderly patients with isolated systolic hypertension and African-American patients
Can cause dizziness, headaches, nausea, flushed skin, ankle edema, constipation, angina, palpitations, symptoms of MI, increased symptoms of GERD or heartburn
Contraindicated in patients with hypersensitivity or severe hypotension. Caution/avoid in patients with renal/hepatic impairment, pregnancy, low blood sugar, Parkinson’s, or depression.
Diuretics: Increase urine output to lower BP (e.g., Hydrochlorothiazide).
Also drug of choice for secondary hypertension caused by kidney disease
Thiazide diuretics: promotes elimination of water and electrolytes. Acts on distal tubule. Decreases vasoconstriction at arterioles, peripheral resistance, and blood volume; stimulates aldosterone secretion leading to increased potassium elimination
Can cause dehydration and low electrolytes, increased urination, hypercalcemia, hyperuricemia, hyperglycemia and glucose intolerance, impotence, photosensitivity
Loop diuretics: Acts on ascending loop of Henle. MOST potent diuretics.
Mainly reserved for patients with impaired renal function
Aldosterone Receptor Antagonists (Spironolactone): about as effective as potassium sparing diuretics; usually used in heart failure, liver disease, and hypokalemia
Also used to treat acne in some patients
Alpha Antagonists: Lower BP by blocking alpha receptors (causes vasodilation); main side effect is postural hypotension (start low, go slow)
Do not stop abruptly, may cause rebound hypertension
Other Agents: Clonidine (alpha antagonist effect; decreases vasoconstriction), methyldopa (alpha antagonist effect; can be used in pregnancy or patients with renal insufficiency).